192 related articles for article (PubMed ID: 19917021)
1. Empirical therapy for serious Gram-positive infections: making the right choice.
Segreti J
Clin Microbiol Infect; 2009 Dec; 15 Suppl 6():5-10. PubMed ID: 19917021
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.
French GL
J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens.
Carpenter CF; Chambers HF
Clin Infect Dis; 2004 Apr; 38(7):994-1000. PubMed ID: 15034832
[TBL] [Abstract][Full Text] [Related]
4. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin.
Skiest DJ
J Clin Microbiol; 2006 Feb; 44(2):655-6. PubMed ID: 16455939
[TBL] [Abstract][Full Text] [Related]
5. [The second life of daptomycin: analysis of a successful come-back].
Decousser JW; Doucet Populaire F
Med Mal Infect; 2008 Dec; 38 Spec No 2():1-3. PubMed ID: 19185200
[No Abstract] [Full Text] [Related]
6. Methicillin-resistant Staphylococcus aureus: the superbug.
Ippolito G; Leone S; Lauria FN; Nicastri E; Wenzel RP
Int J Infect Dis; 2010 Oct; 14 Suppl 4():S7-11. PubMed ID: 20851011
[TBL] [Abstract][Full Text] [Related]
7. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.
Jacobson LM; Milstone AM; Zenilman J; Carroll KC; Arav-Boger R
Pediatr Infect Dis J; 2009 May; 28(5):445-7. PubMed ID: 19295462
[TBL] [Abstract][Full Text] [Related]
8. Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin.
Vikram HR; Havill NL; Koeth LM; Boyce JM
J Clin Microbiol; 2005 Oct; 43(10):5384-7. PubMed ID: 16208025
[TBL] [Abstract][Full Text] [Related]
9. The use of daptomycin for Staphylococcus aureus infections in critical care medicine.
Alder J
Crit Care Clin; 2008 Apr; 24(2):349-63, ix-x. PubMed ID: 18361950
[TBL] [Abstract][Full Text] [Related]
10. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus bloodstream infections: definitions and treatment.
Corey GR
Clin Infect Dis; 2009 May; 48 Suppl 4():S254-9. PubMed ID: 19374581
[TBL] [Abstract][Full Text] [Related]
12. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
Mohan SS; McDermott BP; Cunha BA
Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus.
Rehm SJ; Tice A
Clin Infect Dis; 2010 Sep; 51 Suppl 2():S176-82. PubMed ID: 20731575
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections.
Kanafani ZA; Corey GR
Expert Rev Anti Infect Ther; 2007 Apr; 5(2):177-84. PubMed ID: 17402833
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
Martone WJ; Lamp KC
Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
Rybak MJ
Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721
[TBL] [Abstract][Full Text] [Related]
17. [Role of daptomycin in the empirical and directed therapy of infections caused by Gram-positive bacteria in the critically ill patient].
Garnacho-Montero J; Amaya-Villar R; Gómez-Grande ML; Jerez V; Lorente-Ramos L; Loza A; Martínez A; Pozo JC; Sierra R; Pomares J; de la Torre MV; Ortiz C
Rev Esp Quimioter; 2011 Mar; 24(1):13-24. PubMed ID: 21412665
[TBL] [Abstract][Full Text] [Related]
18. Daptomycin for eradication of a systemic infection with a methicillin-resistant-Staphylococcus aureus in a biventricular assist device recipient.
Weis F; Beiras-Fernandez A; Kaczmarek I; Sodian R; Vicol C; Reichart B; Weis M
Ann Thorac Surg; 2007 Jul; 84(1):269-70. PubMed ID: 17588430
[TBL] [Abstract][Full Text] [Related]
19. Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.
Mangili A; Bica I; Snydman DR; Hamer DH
Clin Infect Dis; 2005 Apr; 40(7):1058-60. PubMed ID: 15825002
[TBL] [Abstract][Full Text] [Related]
20. Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease.
Kuo CC; Wu VC; Huang YT; Liao CH; Hsueh PR
Int J Antimicrob Agents; 2009 Jan; 33(1):96-8. PubMed ID: 18790610
[No Abstract] [Full Text] [Related]
[Next] [New Search]
